Skip to content

Drug Metabolism GRS – 2023

On July 8-9, 2023. Hannah Work presented a poster on her research work on HCV inhibitors.

ASPET 2023

On May 18-21, 2023. The LAMPE Lab presented several of their research works in poster or talk format.

International Conferences on Cytochrome P450

In May 2023, Dr. Lampe was asked by Prof. Fred Guengerich to organize the 2027 International Conference on Cytochrome P450 (http://www.p450meetings.com/future/), which will be held right here in Denver, Colorado!

ISSX

In April 2023, Dr. Lampe was invited to join the International Society for the Study of Xenobiotics (ISSX: https://www.issx.org/) Biotransformation, Mechanisms, and Pathways Focus Group steering committee. Congratulations, Dr. Lampe!

Dalhousie University

On February 7th, 2023. Dr. Lampe gave a presentation in the Department of Pharmacology at Dalhousie University (https://medicine.dal.ca/departments/department-sites/pharmacology.html) in Newfoundland, Canada entitled, “Discovery and development of natural product and PROTAC-based inhibitors of the SARS-CoV-2 main protease, Mpro”.

Per- and polyfluoroalkyl substances (PFAS) inhibit cytochrome P450 CYP3A7 through direct coordination to the heme iron and water displacement

Per- and polyfluoroalkyl substances (PFAS) are a chemical class of highly stable, fluorinated compounds popular for use in a variety of consumer products. PFAS environmental… Read More »Per- and polyfluoroalkyl substances (PFAS) inhibit cytochrome P450 CYP3A7 through direct coordination to the heme iron and water displacement